Jim Kilgallon's Email & Phone Number
Vice President - US Market Access, at Pharmacosmos Therapeutics Inc.
Jim Kilgallon Email Addresses
Jim Kilgallon's Work Experience
Executive Director- US Market Access, Pricing and Contracting
September 2011 to January 2020
Show more
Show less
Frequently Asked Questions about Jim Kilgallon
What is Jim Kilgallon email address?
Email Jim Kilgallon at [email protected] and [email protected]. This email is the most updated Jim Kilgallon's email found in 2024.
What is Jim Kilgallon phone number?
Jim Kilgallon phone number is 9083463409.
How to contact Jim Kilgallon?
To contact Jim Kilgallon send an email to [email protected] or [email protected]. If you want to call Jim Kilgallon try calling on 9083463409.
What company does Jim Kilgallon work for?
Jim Kilgallon works for Pharmacosmos Therapeutics Inc.
What is Jim Kilgallon's role at Pharmacosmos Therapeutics Inc.?
Jim Kilgallon is Vice President, US Market Access
What industry does Jim Kilgallon work in?
Jim Kilgallon works in the Pharmaceuticals industry.
Jim Kilgallon's Professional Skills Radar Chart
Based on our findings, Jim Kilgallon is ...
What's on Jim Kilgallon's mind?
Based on our findings, Jim Kilgallon is ...
Jim Kilgallon's Estimated Salary Range
Jim Kilgallon Email Addresses
Find emails and phone numbers for 300M professionals.
Search by name, job titles, seniority, skills, location, company name, industry, company size, revenue, and other 20+ data points to reach the right people you need. Get triple-verified contact details in one-click.In a nutshell
Jim Kilgallon's Ranking
Ranked #290 out of 5,793 for Vice President, US Market Access in New Jersey
Jim Kilgallon's Personality Type
Introversion (I), Intuition (N), Thinking (T), Judging (J)
Average Tenure
2 year(s), 0 month(s)
Jim Kilgallon's Willingness to Change Jobs
Unlikely
Likely
Open to opportunity?
There's 93% chance that Jim Kilgallon is seeking for new opportunities
Jim Kilgallon's Social Media Links
/in/jim-kilgallon-6906b14 /school/haub/ /company/pharmacosmos-therapeutics-inc